Thane, India

Nayan Shivalkar

This inventor holds 1 USPTO granted patent. Top assignee: Cipla Limited. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nayan Shivalkar. Retrieved from https://idiyas.com/inventor/nayan-shivalkar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nayan Shivalkar: Innovator in Pharmaceutical Chemistry

Introduction

Nayan Shivalkar, based in Thane, India, is a distinguished inventor recognized for his significant contributions to pharmaceutical chemistry. With a unique focus on the separation of diastereomers, Shivalkar has developed innovative processes that improve the efficacy of pharmaceutical compounds.

Latest Patents

Shivalkar holds a patent for an efficient process for the separation of diastereomers of 9-[(R)-2-[[(R,S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl]methoxy]propyl]adenine. This invention details a method not only for separating these complex compounds but also for preparing two distinct derivatives of the adenine compound, thereby enhancing its medicinal applications.

Career Highlights

Currently, Nayan Shivalkar is employed at Cipla Limited, a global leader in the pharmaceutical industry. His role involves leveraging his expertise to develop innovative solutions in drug formulation and delivery. His commitment to advancing pharmaceutical sciences has made him a valuable asset to his team.

Collaborations

Throughout his career, Shivalkar has collaborated with several talented professionals, including Dharmaraj Ramachandra Rao and Ashwini Amol Sawant. These partnerships have fostered a collaborative environment that nurtures creativity and innovation, contributing to the advancement of their collective work in pharmaceutical research.

Conclusion

Nayan Shivalkar is a notable figure in the field of pharmaceutical inventions, offering a profound impact through his patent on diastereomer separation. His work continues to inspire advancements in pharmaceutical processes at Cipla Limited, highlighting the importance of innovation in enhancing therapeutic efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…